EMR·Emerson Electric Co.
EMR|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $1.85 | - | - |
| Q3'26 | $1.69 | $1.71 | +1.0% |
| Q2'26 | $1.53 | $1.54 | +0.4% |
| Q3'25 | $1.62 | $1.62 | +0.3% |
| Q2'25 | $1.51 | $1.52 | +0.7% |
| Q1'25 | $1.41 | $1.48 | +4.6% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $5.1B | - | - |
| Q3'26 | $4.9B | $4.9B | +0.5% |
| Q2'26 | $4.6B | $4.6B | -0.7% |
| Q3'25 | - | $4.9B | - |
| Q2'25 | - | $4.6B | - |
| Q1'25 | - | $4.4B | - |
EMR|Monthly Returns
Market Data
EMR Stock Snapshot
- Market cap
- 83.76B
- P/E ratio
- 32.5
- Day range
- $149.59 – $153.61
- News sentiment
- 71/100 · Bullish
- Analyst target
- $171.81 (+12.4%)
- Consensus
- Buy · 35 analysts
Momentum has flattened on EMR, leaving the next move dependent on news rather than the chart. The stock is liquid enough that positioning changes get absorbed without distorting the trend.
Reverse DCF
What growth is priced into EMR?
At today's price, Emerson Electric Co. needs to grow free cash flow about 24.4% a year for the next 10 years to justify its valuation at a 9.94% cost of capital. Over its actual history it has compounded free cash flow at -3.3% a year, so the market is asking for 27.6 percentage points above its own delivered rate. On that basis EMR looks priced above what its own growth record supports.
- Implied FCF growth
- 24.4%
- Historical FCF CAGR
- -3.3%
- Growth gap
- +27.6 pts
- Verdict
- RICH
- Discount rate (WACC)
- 9.94%
- Beta
- 1.22
Behaviour On Record
What EMR's own history says about today's numbers
- Realized volatility (21d)
- 29.6% 79th pct
- Below its peak
- -8.5%
- vs 200-day average
- +5.5%
- Up days (1y)
- 53%
Emerson Electric Co. is currently running 29.6% annualised volatility over the last 21 sessions. Measured against EMR's own 13 years of daily returns rather than a market-wide average, that is the 79th percentile — elevated for this stock, against a typical reading of 23.3%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
EMR is trading -8.5% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -21.8%, and the deepest was -51.1% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits +5.5% from its 200-day moving average. Against every other day in its history, that gap ranks at the 59th percentile — a somewhat wider gap than its own norm. Over the past year EMR closed higher on 53% of sessions, and it is currently 2 sessions into a rising streak.
On September specifically: over 13 years of records, EMR finished the month higher 6 of 13 times, with a median return of -0.2% and an average of +0.1%. Its strongest month historically has been November at +3.4% on average, its weakest March at -1.8%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: EMR has opened more than 2% away from the prior close in 119 of 3,268 sessions (3.6% of the time), with the largest gaps running +8.8% and -10.3%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 3,269 daily closes between 2013-09-05 and 2026-09-03, split-adjusted, recomputed daily. Percentiles are against EMR's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of EMR's sector?
Emerson Electric Co. sits in the Industrials sector, currently ranked 11th of 11 GICS sectors by relative-strength rotation score (improving).
- Sector rank
- #11 of 11
- Sector state
- Improving
- Sector rotation score
- 20
EMR Competitive Positioning
- EMRyou're hereEmerson Electric Co.$83.8B0.00%
- ETNEaton Corporation plc$150.9B+0.16%
- PHParker-Hannifin Corporation$121.2B-0.02%
- SYMSymbotic Inc.$25.1B-0.30%
- XYLXylem Inc.$24.9B-0.02%
- GNRCGenerac Holdings Inc.$10.6B-0.05%